WashingtonSB 59882025-2026 Regular SessionSenate

Establishing fee authority for accreditation services provided to opioid treatment programs by the department of health.

Sponsored By: June Robinson (Democratic)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

State accreditation fees for opioid treatment programs

Beginning June 11, 2026, Washington’s Department of Health can seek federal approval to accredit opioid treatment programs. Approval from the U.S. Department of Health and Human Services requires the department to follow federally approved policies and procedures. The department must then set initial and renewal fees by rule to cover its accreditation costs. It can use money appropriated from the opioid abatement settlement account to offset those costs. The law sets no fee amounts and creates no direct household payment.

Sponsors & Cosponsors

Sponsor

  • June Robinson

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 109 • No: 35

House vote • 3/4/2026

3rd Reading & Final Passage

Yes: 62 • No: 34 • Other: 2

Senate vote • 2/13/2026

3rd Reading & Final Passage

Yes: 47 • No: 1 • Other: 1

Actions Timeline

  1. Effective date 6/11/2026.

    3/16/2026Senate
  2. Chapter 73, 2026 Laws.

    3/16/2026Senate
  3. Governor signed.

    3/16/2026legislature
  4. Delivered to Governor.

    3/9/2026legislature
  5. President signed.

    3/5/2026legislature
  6. Speaker signed.

    3/5/2026legislature
  7. Rules suspended. Placed on Third Reading.

    3/4/2026Senate
  8. Third reading, passed; yeas, 62; nays, 34; absent, 0; excused, 2.

    3/4/2026Senate
  9. Rules Committee relieved of further consideration. Placed on second reading.

    3/3/2026Senate
  10. Referred to Rules 2 Review.

    3/2/2026Senate
  11. Minority; without recommendation.

    2/27/2026Senate
  12. Minority; do not pass.

    2/27/2026Senate
  13. APP - Majority; do pass.

    2/27/2026Senate
  14. APP - Executive action taken by committee.

    2/27/2026Senate
  15. Referred to Appropriations.

    2/23/2026Senate
  16. Minority; without recommendation.

    2/20/2026Senate
  17. HCW - Majority; do pass.

    2/20/2026Senate
  18. HCW - Executive action taken by committee.

    2/20/2026Senate
  19. First reading, referred to Health Care & Wellness.

    2/17/2026Senate
  20. Third reading, passed; yeas, 47; nays, 1; absent, 0; excused, 1.

    2/13/2026Senate
  21. Rules suspended. Placed on Third Reading.

    2/13/2026Senate
  22. Placed on second reading by Rules Committee.

    2/10/2026Senate
  23. Passed to Rules Committee for second reading.

    2/9/2026Senate
  24. Minority; without recommendation.

    2/9/2026Senate
  25. WM - Majority; do pass.

    2/9/2026Senate

Bill Text

Related Bills

Back to State Legislation